In this study, bile duct ligation was conducted to induce an animal model of extrahepatic cholestasis, targeting the PI3K/AKT/GSK-3β signaling pathway and intestinal flora, to investigate the therapeutic effect of SAL on obstructive cholestatic liver fibrosis and its mechanism. The gene discussed is GSK3B; the disease is extrahepatic cholestasis.